You are here :
Home
Healthcare Market Research Reports
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Asian Fracture Fixation Biomaterials Market The report “The Asian Fracture Fixation Biomaterials market forecast 2012-2018” analyzes the market by technology devices into 7 segments such as Fracture Fixation Bone plates, Screws, Sutures, Rods, Pins and Wires. Some of the key players in The Asian Fracture Fixation Biomaterials market include S&V Technologies, Rayner., InVision Biomedical. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
North American Plastic Surgery Biomaterials market The report “The North American Plastic Surgery Biomaterials market forecast 2012-2018” analyzes the market by technology devices into 5 segments such as Craniofacial Surgery, Soft Tissue Fillers, Acellular Dermal Matrices, Peripheral Nerve Repair, Facial Wrinkle Treatment (Hyaluronic Acid Based) andBio engineered Skins. Some of the key players in The North American Plastic Surgery Biomaterials market include S&V Technologies, Rayner., InVision Biomedical. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
European Plastic Surgery Biomaterials Market The report “The European Plastic Surgery Biomaterials market forecast 2012-2018” analyzes the market by technology devices into 5 segments such as Craniofacial Surgery, Soft Tissue Fillers, Acellular Dermal Matrices, Peripheral Nerve Repair, Facial Wrinkle Treatment (Hyaluronic Acid Based) andBio engineered Skins. Some of the key players in The European Plastic Surgery Biomaterials market include S&V Technologies, Rayner., InVision Biomedical. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
Asian Plastic Surgery Biomaterials Market The report “The Asian Plastic Surgery Biomaterials market forecast 2012-2018” analyzes the market by technology devices into 5 segments such as Craniofacial Surgery, Soft Tissue Fillers, Acellular Dermal Matrices, Peripheral Nerve Repair, Facial Wrinkle Treatment (Hyaluronic Acid Based) andBio engineered Skins. Some of the key players in The Asian Plastic Surgery Biomaterials market include S&V Technologies, Rayner., InVision Biomedical. and others. The segment and country-specific company shares, news & deals, M&A, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this report. |
Upcoming |
|
|
Europe Conventional Injectable Drug delivery Devices Conventional Injectable Drug delivery Devices-Europe market has been pegged at 0.0m in the year 2013 growing at annually and is projected to reach 0.0m by the end of the year 2018. It is segmented on basis of . What makes our report... |
Upcoming |
|
|
North America Conventional Injectable Drug delivery Devices Conventional Injectable Drug delivery Devices-North America market has been pegged at 0.0m in the year 2013 growing at annually and is projected to reach 0.0m by the end of the year 2018. It is segmented on basis of . What makes our report... |
Upcoming |
|
|
Asian Cataract Surgery Devices Peers of Cataract Surgery Devices-Asia are Intraocular Lens (IOL), Phacoemulsification Devices and Ophthalmic Viscoelastic Devices (OVD) comprising 71.0%, 15.0% and 14.0% respectively of the Global Ophthalmology Cataract Surgery Devices market. It is segmented... |
Upcoming |
|
|
Asian Ophthalmology Surgery Devices The Asian ophthalmology surgery devices market is projected to grow at a CAGR of 9.88%, which is considered as one of the biggest market for such surgical devices. This report provides the market share, value chain analysis, and market drivers, restraints, and upcoming opportunities. A DeepDive analysis of key players in this market has also been considered in this report. |
Upcoming |
|
|
European Ophthalmology Surgery Devices Europe is considered as the second largest market in ophthalmology surgery devices, with a 25.41% market share, and it is expected to grow at a CAGR of 3.69% from 2012 to 2018. The European ophthalmology surgery devices report offers a comprehensive analysis of key market drivers, restraints, and upcoming opportunities. It also focuses on the current market trends and provides key market profiles of companies thriving in this market. |
Upcoming |
|
|
European Partition Chromatography Reagents The European partition chromatography reagents market is considered as the second largest market in this segment. It constitutes of 29.4% of the global partition chromatography reagents market, which is poised to grow at a CAGR of 6.89% from 2012 to 2018. |
Upcoming |
|
|
North American Partition Chromatography Reagents The North American Partition Chromatography Reagents market has the highest market share of 41.3%, simultaneously followed by Europe and Asia. The growth of the partition chromatography market is being fueled by the recent expansion of biotechnology and pharmaceutical industries. |
Upcoming |
|
|
North American Normal phase/hydrophilic interaction columns Normal phase/hydrophilic interaction columns-North America market has been pegged at 27.1m in the year 2013 growing at 4.2% annually and is projected to reach 33.3m by the end of the year 2018. Normal phase/hydrophilic interaction columns-North America... |
Upcoming |
|
|
European Healthcare Workflow Systems Peers of Hydrocolloids are Payer Claim Management, Customer Relationship Management (HCIT), Pharmacy Audit And Analysis and Fraud Detection comprising 35.8%, 25.2%, 20.9% and 18.1% respectively of the Global Workflow Solutions market. It is segmented on basis... |
Upcoming |
|
|
North American Healthcare Workflow Systems The North American healthcare workflow systems report defines and segments the concerned market in North America with analysis and forecast of revenue. The market was valued at $5318.0 million in 2013 and is projected to witness a CAGR of 5.9% between 2014 and 2019. |
Upcoming |
|
|
European Dermatology Treatment Devices The dermatology treatment devices market in Europe is expected to grow at a CAGR of 12.5% from 2012 to 2018. The market dynamics, along with the drivers and restraints for this market, have been elaborated in this report. |
Upcoming |
|
|
Asian Dermatology Treatment Devices In the Asian region, the demand for laser devices such as argon, pulsed dye, and intense pulse light laser has increased in the recent past. The geographies segment comprises major countries in this region, which includes China, Japan, and India. |
Upcoming |
|
|
European Claim Management System The European payer claim management market has gained a significant share in the total payer claim management market. The market was pegged at $753 million in 2013 and is estimated to grow at a CAGR of 5.3% in the forecasted years. The market can be segmented on the basis of types and various types of deployments and componenets, the report further segments the market into major geographies, end users, companies, and macro indicators. Deep-dive analysis of the top players of this market have been considered in this report |
Upcoming |
|
|
Asia Acylation Reagents The acylation reagents market in Asia is expected to grow at a CAGR of 8.2% from 2013 to 2018. Companies that operate in this market are Agilent Technologies, GE Healthcare Life Sciences, and Helena Laboratories, among others. |
Upcoming |
|
|
European Acylation Reagents Companies that offer acylation reagents as products focus on this region for strategic expansion. The market is segmented and forecast based on geographies, which comprises major countries in this region, including the U.K., France, and Germany. |
Upcoming |
|
|
North American Acylation Reagents The U.S. accounted for the largest share in the North American acylation reagents market in 2013. The market in this region is majorly driven by an increased use of these agents as biocatalysts in research activities to develop new and advanced drugs. |
Upcoming |
Healthcare
